|
Market Closed -
Euronext Paris
11:55:00 2026-11-03 EST
|
5-day change | 1st Jan Change | ||
| 0.0750 EUR | 0.00% |
|
-26.47% | -43.61% |
| 10-29 | IntegraGen SA Reports Earnings Results for the Half Year Ended June 30, 2026 | CI |
| 10-12 | ABL Texcell Diagnostics to Acquire French Biotech Company IntegraGen | MT |
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| INTEGRAGEN | Bio Diagnostics & Testing | 0.00% | -26.47% | -43.61% | -50.33% | -93.88% | 554K |  |  | |
- Stock Market
- Stocks
- ALINT Stock
- Charts IntegraGen
- Relative Strength Chart
Select your edition
All financial news and data tailored to specific country editions
